Effects of Cerebrolysin™ on amyloid-β deposition in a transgenic model of Alzheimer’s disease
- 1 January 2002
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Toward the Characterization and Identification of γ-Secretases Using Transition-state Analogue InhibitorsAnnals of the New York Academy of Sciences, 2006
- Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42Journal of Neuroscience Research, 2001
- The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signalingProgress in Neurobiology, 1998
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Expression patterns of β‐amyloid precursor protein (β‐APP) in neural and nonneural human tissues from alzheimer's disease and control subjectsAnnals of Neurology, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Evidence that β-Amyloid Protein in Alzheimer's Disease Is Not Derived by Normal ProcessingScience, 1990
- Patterns of gliosis in alzheimer's disease and aging cerebrumGlia, 1989
- Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's diseaseNeurobiology of Aging, 1988
- Some morphometric aspects of the brain in senile dementia of the alzheimer typeAnnals of Neurology, 1981